Biotechnology & Life Sciences Assessment

Evaluate the science.
Understand the opportunity.
Make the decision.

Independent assessment of biotechnology and life sciences opportunities across scientific rationale, evidence, technical feasibility, translational potential, development assumptions and risk.

What this means

Life sciences decisions require more than understanding the science in isolation.

Biotechnology opportunities often sit at the intersection of discovery science, technology development, experimental evidence, engineering, clinical or translational considerations and commercial assumptions. A decision can depend on how those pieces fit together rather than on any single result.

reynarun provides an independent perspective across those boundaries. We examine the scientific rationale and supporting evidence while considering the technical requirements, development assumptions and intended application that give the science its practical significance.

The result is a clearer understanding of the opportunity: what has actually been demonstrated, what is reasonably supported by the evidence, what remains uncertain, and which questions deserve further investigation before an important decision is made.

Questions we address

The important question is not simply whether the science is interesting.

Biotechnology assessment can be structured around a company, platform, technology, research result, therapeutic concept, development program, partnership or investment opportunity. The work focuses on the scientific and technical questions that materially affect the decision.

01

How strong is the scientific foundation?

Evaluate scientific rationale, evidence quality, experimental support, competing interpretations and the extent to which the available evidence supports the claims being made.

02

What has actually been demonstrated?

Distinguish demonstrated performance from assumptions, projections and proposed future capabilities across the relevant technology or development pathway.

03

What must be true for the opportunity to succeed?

Identify technical dependencies, development requirements, translational assumptions and unresolved questions that could materially affect the outcome.

04

Where should attention go next?

Identify the experiments, evidence, technical validation or analysis that would most meaningfully improve confidence in the opportunity or inform the next decision.

Assessment capability

Connect the scientific evidence to the real-world opportunity.

Strong biotechnology assessment requires understanding both the scientific details and the context in which those details matter. reynarun evaluates the evidence in relation to technical feasibility, development assumptions and intended application.

Scientific rationale & evidence

Scientific mechanisms, literature, experimental findings, reproducibility, evidence quality, competing hypotheses and interpretation of results.

Technology & development

Technical platforms, development pathways, dependencies, performance requirements, scalability considerations and assumptions underlying future capabilities.

Translation & decision relevance

Connect scientific and technical findings to the intended application, development strategy, investment thesis or broader organizational decision.

Where it applies

Independent biotechnology assessment across the life sciences landscape.

The scope of an assessment can be narrow or broad. reynarun can evaluate a specific scientific or technical question or examine the relevant components of an entire opportunity.

The work is particularly useful when decision-makers need an independent technical perspective before allocating capital, entering a relationship, advancing a program or relying on an important scientific assumption.

Biotechnology platforms Evaluate scientific foundations, technical capabilities and development assumptions behind emerging platforms.
Therapeutic opportunities Assess scientific rationale, evidence, technical feasibility and key assumptions within therapeutic development opportunities.
Life sciences technologies Evaluate technologies, tools and technical approaches supporting research, development or commercialization.
Investment & due diligence Provide independent scientific and technical perspective for investors evaluating life sciences opportunities.
Partnerships & licensing Examine scientific and technical fit, evidence, dependencies and development assumptions underlying proposed relationships.
Research & development programs Evaluate scientific direction, technical priorities, program structure and evidence supporting development decisions.
Experience behind the work

The capability predates the reynarun name.

reynarun is the current firm through which this scientific, technical and advisory work is being delivered and expanded. Its foundation is the body of work conducted through Continuum beginning in 2018.

Led by Jeremy Gawryluk, PhD, that work has involved technically complex environments requiring the evaluation of evidence, integration of expertise across disciplines and careful distinction between what was demonstrated and what remained an assumption.

The transition to reynarun represents an expansion of that capability: bringing the experience developed through individual engagements into a dedicated firm focused on actively delivering independent scientific, technical and strategic assessment.

The name is new. The scientific and technical experience behind the work is established.
How an assessment works

From scientific complexity to a decision-ready assessment.

Every engagement is different, but the process is designed to keep the work focused on the decision rather than allowing the assessment to become an exercise in collecting information for its own sake.

1

Define

Establish the opportunity, decision, scientific question, available evidence and scope of the assessment.

2

Examine

Review scientific evidence, technical claims, assumptions, dependencies, limitations and competing interpretations.

3

Evaluate

Determine what the evidence supports, what remains uncertain and which findings are material to the opportunity.

4

Advise

Deliver a clear assessment of the opportunity and identify the evidence, validation or decisions that should follow.

Have a biotechnology opportunity to evaluate?

Tell us what you're looking at and what decision depends on the answer.

Start a Conversation